Objective: This study examines the extent to which cybersecurity attacks on autonomous vehicles (AVs) affect human trust dynamics and driver behavior.
Background: Human trust is critical for the adoption and continued use of AVs. A pressing concern in this context is the persistent threat of cyberattacks, which pose a formidable threat to the secure operations of AVs and consequently, human trust.
Method: A driving simulator experiment was conducted with 40 participants who were randomly assigned to one of two groups: (1) Experience and Feedback and (2) Experience-Only. All participants experienced three drives: Baseline, Attack, and Post-Attack Drive. The Attack Drive prevented participants from properly operating the vehicle in multiple incidences. Only the "Experience and Feedback" group received a security update in the Post-Attack drive, which was related to the mitigation of the vehicle's vulnerability. Trust and foot positions were recorded for each drive.
Results: Findings suggest that attacks on AVs significantly degrade human trust, and remains degraded even after an error-less drive. Providing an update about the mitigation of the vulnerability did not significantly affect trust repair.
Conclusion: Trust toward AVs should be analyzed as an emergent and dynamic construct that requires autonomous systems capable of calibrating trust after malicious attacks through appropriate experience and interaction design.
Application: The results of this study can be applied when building driver and situation-adaptive AI systems within AVs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/00187208241283321 | DOI Listing |
BMC Med
January 2025
Health Emergencies Programme, World Health Organization, Geneva, Switzerland.
Background: Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under "exceptional circumstances" based on effectiveness found in pre-clinical challenge studies in animals and safety studies in humans showing minimal side effects. As clinical efficacy studies are still ongoing, there is currently limited information with regard to the acceptability of tecovirimat to treat mpox.
View Article and Find Full Text PDFBMC Health Serv Res
January 2025
Department of Health Services Research, Faculty of Health, Medicine and Life Sciences, CAHPRI, Maastricht University Medical Center, Maastricht University, P.O. Box 616, Maastricht, 6200 MD, the Netherlands.
Background: This study explores the facilitating and inhibiting factors in the design/development, implementation, and applicability/evaluation of value-based payment models of integrated care. The Delphi technique was used to reach consensus among a panel of (inter)national experts on these factors.
Methods: An expert panel of 15 members participated in a three-round Delphi study.
BMC Public Health
January 2025
School of Management, Shanxi Medical University, 56 Xinjian South Road, Taiyuan, Shanxi, China.
Background: Depression is one of the most common mental health problems in older adults. Community social capital and depressive symptoms in older adults have been discussed in previous studies but remain limited. This study aims to explore the association between community social capital and depressive symptoms among older adults relocated for poverty alleviation in China.
View Article and Find Full Text PDFBJPsych Open
January 2025
Division of Psychology and Mental Health, School of Health Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Background: Co-occurring self-harm and aggression (dual harm) is particularly prevalent among forensic mental health service (FMHS) patients. There is limited understanding of why this population engages in dual harm.
Aims: This work aims to explore FMHS patients' experiences of dual harm and how they make sense of this behaviour, with a focus on the role of emotions.
J Community Genet
January 2025
Department of Organization and Management in Health Care, Poznan University of Medical Sciences, Poznań, Poland.
Background: Despite the rise of research biobanks in the Middle East, they continue to struggle with the limited number of donors. Although qualified healthcare professionals may address it, the awareness of biobanks among future physicians is low. This paper assesses the attitudes towards research biobanks among Iranian medical students.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!